Pórszász, RóbertMariadasan, Lydia2015-11-162015-11-162015-02http://hdl.handle.net/2437/218340Type 2 diabetes mellitus is a chronic metabolic disorder that results from defects in both insulin secretion and insulin action. Type 2 diabetes can initially be treated with oral agent monotherapy, but due to the progressive nature of this disorder, patients eventually require the addition of other oral agents, often as a prelude to insulin therapy. Several new approaches are developed to improve glycemic control with minimum side effects.40endiabetes mellitus type 2anti-diabetic drugssulfonylureasrapid-acting insulin secretagoguesmetforminthiazolidinedionesα-glucosidase inhibitorsincretin analogue based therapies 19 glucagon-like-peptide-1 receptor agonistdipeptidyl peptidase-4 inhibitorssodium-glucose co-transporter type 2 inhibitorspramlintideUNL Thread List::Medicine